Katano, Japan

Chiho Fukiage

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2000-2003

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Chiho Fukiage: Innovator in Retinal Research**

Introduction

Chiho Fukiage, a brilliant inventor based in Katano, Japan, has made significant contributions to the field of retinal research. With a total of four patents to her name, she is dedicated to advancing the understanding and treatment of eye-related conditions.

Latest Patents

Fukiage's most recent patents include a groundbreaking invention focused on calpain and DNA encoding the same. This invention involves a unique calpain protein that is specific to retina tissues, characterized by a specific amino acid sequence outlined in SEQ ID NO: 1. Additionally, her patent includes a DNA representation detailed in SEQ ID NO: 2, which encodes this calpain protein along with a vector containing the DNA, a transformant that has been successfully transformed by this vector, and a comprehensive process for producing the calpain protein through culturing the transformant.

Career Highlights

Chiho Fukiage is currently employed at Senju Pharmaceutical Co., Ltd., where she applies her expertise in developing innovative treatments and therapies related to ocular health. Her dedication to research and development in this specialized field has positioned her as a key contributor to ongoing advancements in medicine.

Collaborations

Throughout her career, Fukiage has collaborated with distinguished colleagues, including Mitsuyoshi Azuma and Jun Inoue. These partnerships have fostered a productive research environment and have facilitated the sharing of ideas and knowledge vital for innovation.

Conclusion

Chiho Fukiage is a noteworthy inventor whose work continues to influence the field of retinal research. Her patents reflect a commitment to improving patient outcomes and advancing scientific understanding in ocular health. With continued collaboration and innovation, she is setting the stage for future breakthroughs in this essential area of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…